Results 181 to 190 of about 64,832 (295)

Translational and Randomized Study of 5-HT3 Receptor Antagonists for Evaluation of Chemotherapy-induced Nausea and Vomiting Related Biomarkers

open access: diamond, 2019
Yukari Tsubata   +10 more
openalex   +2 more sources

Wirksamkeit von Akupressur auf Chemotherapieinduzierte Nausea und Vomitus bei Mammakarzinom-Patientinnen [Ressource électronique]: systematische Literaturreview [PDF]

open access: yes, 2018
Mit dieser systematischen Literaturreview soll ein Überblick zum aktuellen Forschungsstand geschaffen werden. Falls die Wirksamkeit von Akupressur auf CINV bei Mammakarzinom-Patientinnen bewiesen wird, soll Pflegenden und Pflegestudierenden eine ...
Hugo, Julia   +2 more
core  

The Cannabinoid System as a Potential Novel Target for Alcohol‐Associated Liver Disease: A Propensity‐Matched Cohort Study

open access: yesLiver International, Volume 45, Issue 11, November 2025.
ABSTRACT Background Alcohol‐associated liver disease (ALD) is a leading cause of liver‐related morbidity and mortality, yet effective therapeutic options remain limited. Preclinical data suggest that modulation of the hepatic endocannabinoid system, particularly via cannabidiol (CBD), may reduce alcohol‐induced liver injury.
Butros Fakhoury   +6 more
wiley   +1 more source

Development of Novel Anticancer Pyrazolopyrimidinones Targeting Glioblastoma

open access: yesChemMedChem, Volume 20, Issue 20, October 15, 2025.
Pyrazolo[1,5‐α]pyrimidinone derivatives exhibit selective cytotoxicity towards glioblastoma (GBM) cells over noncancerous cells. Structure–activity relationship studies identifies a lead compound with significant cytotoxicity activity, inducing apoptosis and necrosis in GBM cells, without affecting noncancerous cells. This demonstrates the potential of
Kate Byrne   +5 more
wiley   +1 more source

Liver‐directed therapies for colorectal liver metastases

open access: yesCancer, Volume 131, Issue 20, 15 October 2025.
Abstract Colorectal cancer is the third most common cancer diagnosed in the United States, with an anticipated 53,000 deaths from this disease in 2025. Greater than one in five patients will present with synchronous colorectal liver metastases (CRLMs), and 25%–30% will develop CRLMs during the course of the disease.
Andrew D. Folkerts   +2 more
wiley   +1 more source

A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination with bevacizumab

open access: yesTherapeutics and Clinical Risk Management, 2016
Mary Lou Affronti,1–3 Sarah Woodring,1,2 Katherine B Peters,1,4 James E Herndon II,5 Frances McSherry,5 Patrick N Healy,5 Annick Desjardins,1,4 James J Vredenburgh,6 Henry S Friedman1,2 1The Preston Robert Tisch Brain Tumor Center at Duke ...
Affronti ML   +8 more
doaj  

Ginger - mechanism of action in chemotherapy-induced nausea and vomiting: A review [PDF]

open access: green, 2017
Wolfgang Marx   +6 more
openalex  

Home - About - Disclaimer - Privacy